Clinical Trial: A Post-marketing Clinical Study Evaluating the Protective Effect of the Oral Recombinant Subunit B / Bacterial Cholera Vaccine (Intestinal Capsule) Against Infectious Diarrhea in Healthy Children

U.S., Dec. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07300462) titled 'A Post-marketing Clinical Study Evaluating the Protective Effect of the Oral Recombinant Subunit B / Bacterial Cholera Vaccine (Intestinal Capsule) Against Infectious Diarrhea in Healthy Children' on Dec. 10.

Brief Summary: Chinese survey data indicate that the incidence rate of diarrhea in the general population ranges from 0.17 to 0.70 episodes per person-year, whereas among children under five years of age, the rate is significantly higher, ranging from 2.50 to 3.38 episodes per person-year. Over recent decades, rapid economic development has contributed substantially to the reduction of mortality associated with infectious disea...